Of course, tamoxifen does have its hazards, including increased risk for potentially fatal blood clots, as well as cancer of the uterine lining. For some women at a high enough risk for breast cancer, it's worth it. Now technological improvements will enable many more women to test for the BRCA1 and BRCA2 genes, which are thought to increase a woman's susceptibility for breast cancer. The more women know about their risk, the better they will be able to balance a growing number of treatment options. What may surprise some is that mastectomy is not necessarily the best option.
Some doctors are still reluctant to use the latest technology.
They often want to see the results of new treatment methods over time. And before they do anything, get a second opinion. Inc. All rights reserved.